Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Development of Neuroregenerative Gene Therapy to Reverse Glial Scar Tissue Back to Neuron-Enriched Tissue

Frontiers in Cellular Neuroscience(2020)10.3389/fncel.2020.594170Source: DataRank Database

Development of Neuroregenerative Gene Therapy to Reverse Glial Scar Tissue Back to Neuron-Enriched Tissue is a research paper published in Frontiers in Cellular Neuroscience (2020). On theSindex it has a DataRank of 0. It has been cited 81 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access81 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 3.76)OA: goldTopics (29)Linked Datasets (12)DataCite Reuse (12)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Zhuofan Lei ORCID,Ziyuan Guo ORCID,Zifei Pei ORCID,Yu‐Chen Chen ORCID,Fengyu Zhang ORCID

Live enrichment

PubMed:33250718 PMC:PMC7674596 OpenAlex:https://openalex.org/W3097059144

NIA NIH HHS

Grant: R01 AG045656

NIMH NIH HHS

Grant: R01 MH083911

National Institutes of Health

Grant: 5R01MH083911-03

GABAergic Synapse Assembly: Extrasynaptic GABAAR Targeting

National Institutes of Health

Grant: 5R01AG045656-03

Converting Alzheimer's reactive astrocytes into functional neurons

FWCI

3.76

Citation Percentile

0.9%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.3389/fncel.2020.594170

publisherhttps://doi.org/10.3389/fncel.2020.594170

publisherhttps://www.frontiersin.org/articles/10.3389/fncel.2020.594170/full

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33250718

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7674596

Fields of Study

Nerve injury and regenerationNeurogenesis and neuroplasticity mechanismsVirus-based gene therapy research0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

Glial scarAstrocyteMicrogliaNeuroscienceNeuroinflammationNeuronBiologyNeurogliaRegeneration (biology)Central nervous systemCell biologyImmunologyInflammationBrain injuryblood-brain-barrierBrain RepairNeurod1In Vivo ReprogrammingAstrocyte-to-neuron ConversionNeuron To Astrocyte RatioCellular NeuroscienceNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571

Sustainable Development Goals

SDG 0: Good health and well-being

Additional file 4 of In vivo neural regeneration via AAV-NeuroD1 gene delivery to astrocytes in neonatal hypoxic-ischemic brain injury

10.6084/m9.figshare.26749994.v1figshare

Additional file 6 of In vivo neural regeneration via AAV-NeuroD1 gene delivery to astrocytes in neonatal hypoxic-ischemic brain injury

10.6084/m9.figshare.26750000figshare

Additional file 6 of In vivo neural regeneration via AAV-NeuroD1 gene delivery to astrocytes in neonatal hypoxic-ischemic brain injury

10.6084/m9.figshare.26750000.v1figshare

Additional file 2 of In vivo neural regeneration via AAV-NeuroD1 gene delivery to astrocytes in neonatal hypoxic-ischemic brain injury

10.6084/m9.figshare.26749988.v1figshare

Additional file 1 of In vivo neural regeneration via AAV-NeuroD1 gene delivery to astrocytes in neonatal hypoxic-ischemic brain injury

10.6084/m9.figshare.26749985figshare

Additional file 1 of In vivo neural regeneration via AAV-NeuroD1 gene delivery to astrocytes in neonatal hypoxic-ischemic brain injury

10.6084/m9.figshare.26749985.v1figshare

Additional file 2 of In vivo neural regeneration via AAV-NeuroD1 gene delivery to astrocytes in neonatal hypoxic-ischemic brain injury

10.6084/m9.figshare.26749988figshare

Additional file 4 of In vivo neural regeneration via AAV-NeuroD1 gene delivery to astrocytes in neonatal hypoxic-ischemic brain injury

10.6084/m9.figshare.26749994figshare

Additional file 3 of In vivo neural regeneration via AAV-NeuroD1 gene delivery to astrocytes in neonatal hypoxic-ischemic brain injury

10.6084/m9.figshare.26749991figshare

Additional file 5 of In vivo neural regeneration via AAV-NeuroD1 gene delivery to astrocytes in neonatal hypoxic-ischemic brain injury

10.6084/m9.figshare.26749997figshare

Additional file 3 of In vivo neural regeneration via AAV-NeuroD1 gene delivery to astrocytes in neonatal hypoxic-ischemic brain injury

10.6084/m9.figshare.26749991.v1figshare

Additional file 5 of In vivo neural regeneration via AAV-NeuroD1 gene delivery to astrocytes in neonatal hypoxic-ischemic brain injury

10.6084/m9.figshare.26749997.v1figshare

Related Papers (8)

Advances in the Signaling Pathways Downstream of Glial-Scar Axon Growth Inhibitors

N/A

0.646DataRank · unranked

Frontiers in Cellular Neuroscience(2020)

co-citedsame journal

10.3389/fncel.2020.00174

Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

Top 2%

7.7DataRank

The Lancet Neurology(2021)

co-cited

10.1016/s1474-4422(21)00252-0

Revisiting astrocyte to neuron conversion with lineage tracing in vivo

Cell(2021)

co-cited

10.1016/j.cell.2021.09.005

Isolation of mouse brain-infiltrating leukocytes for single cell profiling of epitopes and transcriptomes

STAR Protocols(2021)

co-cited

10.1016/j.xpro.2021.100537

New AAV tools fail to detect Neurod1-mediated neuronal conversion of Müller glia and astrocytes in vivo

EBioMedicine(2023)

co-cited

10.1016/j.ebiom.2023.104531

Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup

N/A

1.2DataRank · unranked

Alzheimer s & Dementia(2024)

co-cited

10.1002/alz.13859

Astrocytic Slc4a4 regulates blood-brain barrier integrity in healthy and stroke brains via a CCL2-CCR2 pathway and NO dysregulation

Cell Reports(2024)

co-cited

10.1016/j.celrep.2024.114193

Neurons derived from NeuroD1-expressing astrocytes transition through transit-amplifying intermediates but lack functional maturity

N/A

0.370DataRank · unranked

Science Advances(2025)

co-cited

10.1126/sciadv.adw9296